Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA

Journal of Drug Targeting

Volumn 4, Issue 2, 1996, Pages 109-116

  Swart, P J ^a   Beljaars, E ^a   Smit, C ^a   Pasma, A ^a   Schuitemaker, H ^b   Meijer, D K F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aco HSA; AIDS; HIV; Immunogenicity; Pharmacokinetics; Polyanions; Suc HSA; Toxicity

Indexed keywords

ANTIVIRUS AGENT; CELL RECEPTOR; DEXTRAN SULFATE; DRUG CARRIER; FLUORESCEIN; FORMALDEHYDE; HEPARIN; HUMAN SERUM ALBUMIN; LYSINE; POLYINOSINIC ACID; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD CLOTTING; CELL PROLIFERATION; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; HEMATOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; LYMPHOCYTE; MACROPHAGE; MALE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SPLEEN CELL;

EID: 0029823015     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869609046269     Document Type: Article

References (16)

1. Abraham, R., Singh, N., Mukhopadhyay, A., Basu, S.K., Bal, V. and Rath, S. (1995) Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J. Immunol., 154:1-8.
2. Allen, T.M. (1988) Toxicity of drug carriers to the mononuclear phagocyte system. Adv. Drug Deliv. Rev., 2:55-67.
3. 131I labelled human growth hormone of high specific radioactivity. Biochem. J., 89:114-123.
4. Groenink, M., Swart, P.J., Broersen, S., Kuipers, M., Meijer, D.K.F. and Schuitemaker, H. (1996) Potent inhibition of replication of primary HIV-1 isolates by negatively charged human serum albumin. AIDS Res. Human. Retrovirol, submitted for publication.
5. Harms, G., Dijkstra, C.D., Lee, Y.C. and Hardonk, M.J. (1990) Glycosyl receptors in macrophage subpopulations of rat spleen and lymph node. A comparative study using neoglycoproteins and monoclonal antibodies ED1, ED2 and ED3. Cell Tissue Res., 262:35-40.
6. Jansen, R.W., Molema, G., Pauwels, R., Schols, D., De Clercq, E. and Meijer, D.K.F. (1991) Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. Mol. Pharmacol., 39:818-823.
7. Jansen, R.W., Schols, D., Pauwels R., De Clercq, E., Meyer D.K.F. (1993a) Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus Type I activity Mol. Pharmacol., 44:1003-1007.
8. Jansen, R.W., Olinga, P., Harms, G. and Meijer, D.K.F. (1993b) Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver. Pharm. Res., 10:1611-1614.
9. Jobbágy, A. and Király, K. (1966) Chemical characterization of fluorescein isothiocyanate-protein conjugates. Biochim. Biophys. Acta, 124:166-175.
10. Kuipers, M.E., Huisman, J.G., Swart, P.J., de Béthune, M., Pauwels, R., De Clercq, E., Schuitemaker, H. and Meijer, D.K.F. (1996) Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120. J. Acq. Immun. Defic. Synd. Hum. R., in press.
11. Maeda, H., Ishida, N., Kawauchi, H. and Tuzimura, K. (1969) Reaction of Fluorescein-isothiocyanate with proteins and aminoacids. J. Biochem. (Tokyo), 65:777-783.
12. Proost, J.H. and Meijer, D.K.F. (1992) MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput. Biol. Med., 22:155-163.
13. Swart, P.J., Suc, C.S., Kuipers, M.E., Asuncion, C., Josephs, S., Smit, C., and Meijer, D.K.F. (1996) The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin. AIDS Res. Human Retrovirol., submitted for publication.
14. Takakura, Y., Hashida, M., and Sezaki, H. (1992) Lymphatic transport after patenteral drug administration. In Charman, W.N. and Stella, V.J. (eds), Lymphatic transport of drugs (Boca Raton: CRC Press Inc), pp. 255-277.
15. Van Lier, R.A.W., Boot, J.H.A., Verhoeven, A.J., De Groot, E.R., Brouwer, M.A. and Aarden, L.A. (1987) Functional studies with anti-CD3 heavy chain isotype switch variant monoclonal antibodies. J. Immunol. 139:2873-2879.
16. Van Lier, R.A.W., Brouwer, M., Rebel, V.I., Noesel, C.J.M. and Aarden, L.A. (1989) Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology, 68:45-50.